ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-TLR9 Antibody (A283239)

This product is discontinued

Anti-TLR9 Antibody (A283239) has been discontinued and is no longer available.

View all TLR9 Antibodies.

Name
Anti-TLR9 Antibody
Description
Goat polyclonal antibody to TLR9.
Specificity
This antibody recognises an epitope within the N-terminal region of CD289, otherwise known as Toll-like receptor 9 (TLR9), a type I transmembrane glycoprotein and member of the toll-like receptor family, which triggers MyD88 and TRAF6, resulting in NF-kappaB activation, cytokine secretion and the inflammatory response. CD289 acts as a receptor for unmethylated cytidine-phosphate-guanosine dinucleotides in bacterial DNA (CpG-DNA), playing a primary role in pathogen recognition and activation of innate immunity. Goat anti Human CD289 antibody is suitable for use in immunocytochemistry on acetone fixed cells.
Applications
WB, IHC-P
Dilutions
IHC-P 1: 1:250, WB: 1:1,000
Reactivity
Human, Mouse
Immunogen
Synthetic peptide sequence SLKYNNLTVVPRNLPSSLEYLLLSYNRIVKL corresponding to amino acids 205-235 within the N-terminal domain of human CD289.
Sequence
SLKYNNLTVVPRNLPSSLEYLLLSYNRIVKL
Host
Goat
Clonality
Polyclonal
Isotype
IgG
Conjugate

Unconjugated

Concentration
1 mg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.1% Sodium Azide.
Storage
Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.
Synonyms
CD289, Toll-like receptor 9
Isotype Controls
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-TLR9 Antibody (A283239)

Proteins predicted to interact with TLR9

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.7% Relevancy Score
99.2% Relevancy Score
98.8% Relevancy Score
98.8% Relevancy Score
98.2% Relevancy Score
97.9% Relevancy Score
97.5% Relevancy Score
97% Relevancy Score